Background Iron Deficiency Anemia (IDA) affects approximately 40% of school-age children worldwide, with first-grade girls representing a priority population for early prevention and intervention. Objective To establish the psychometric properties of the Family-Centered Questionnaire based on Intervention Mapping to Encourage Iron Deficiency Anemia Prevention in First-Grade Schoolgirls (FCIDAS). Methods In this psychometric validation study conducted in Torbat Heydariyeh, Iran, 296 mothers were selected by multistage stratified sampling (98.7% response rate). Content validity was verified by 15 experts (I-CVI = 0.78, S-CVI = 0.92). Psychometric evaluation included exploratory factor analysis (principal axis factoring with Promax rotation), convergent validity (AVE ≥ 0.50), discriminant validity (Fornell-Larcker criterion), test-retest reliability (14-day interval, n = 54, ICC[2,1]), and measurement error (Bland-Altman analysis, SEM, SDC). Model fit was assessed using the following indices: χ 2 /df < 3, CFI > 0.95, TLI > 0.95, RMSEA < 0.06, and SRMR < 0.08. Results Exploratory factor analysis supported a seven-factor model (45 items) explaining 62.28% of the variance, demonstrating acceptable preliminary psychometric properties: CFI = 0.960, TLI = 0.957, RMSEA = 0.048, and SRMR = 0.065. Factor loadings ranged from 0.52 to 0.93 (p < 0.001). Internal consistency (McDonald's ω) ranged from 0.687 to 0.938 (total ω = 0.872). Average variance extracted exceeded 0.50 for all constructs (range: 0.51–0.78). Test-retest reliability at a 14-day interval (n = 54) gave an ICC of 0.89. Measurement errors were acceptable (SEM = 8.20 points; SDC = 22.71 points), and floor and ceiling effects were negligible (<1% and <5%). Of the 12 pre-specified construct validity hypotheses, 10 were confirmed (83.3%). Conclusion The FCIDAS demonstrated sound psychometric properties in an Iranian sample and provides a reliable measure of maternal prevention behaviors regarding iron deficiency anemia in first-grade schoolgirls. As the first validated instrument for maternal IDA prevention in Iran, the FCIDAS incorporates an Intervention Mapping framework, reflects culturally specific features, and captures a theoretically grounded factor structure. Trial registration number IRCT20160824029512N2. This trial was registered on April 5, 2022, under the identifier 59972.
No takes yet. Share an insight, caveat, or question.
Pourhaji et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: